Settling Microbe Concentration Testing in Cleanrooms: Settle Plate Method, Standards, and Acceptance

Settling microbe concentration testing, also known as the settle plate method, is a core microbiological monitoring technique used to evaluate viable airborne contamination in cleanrooms and controlled environments. By exposing sterile culture plates to the air for a defined period and counting the resulting colony-forming units (CFU), this method provides critical data for cleanroom qualification, routine environmental monitoring, and GMP regulatory compliance. This article explains the principle, standards, procedures, acceptance criteria, and practical applications of settling microbial concentration determination.

Technical Overview

Settling microbe concentration determination is a passive air sampling technique that measures the number of viable airborne microorganisms that deposit by gravity onto a standard culture medium plate over a defined exposure period. Because microorganisms in the air are typically attached to dust particles or droplet nuclei, they gradually settle onto exposed surfaces, including hands, equipment, and product. The settle plate method simulates exactly this contamination pathway, making it one of the most widely used indicators of microbiological surface contamination risk in controlled environments.

During the test, sterile Petri dishes (typically 90 mm in diameter) filled with nutrient agar are placed at representative locations within the cleanroom at working height. The lids are opened for a specified exposure duration, after which the plates are closed, incubated, and examined. Each visible colony is counted, and the result is expressed as colony-forming units per plate per exposure period, commonly normalized to CFU per 4-hour exposure in pharmaceutical practice.

The method is primarily governed by the following standards and regulations:

• GB/T 16294-2010, Test method for settling microbe concentration in cleanrooms of the pharmaceutical industry
• ISO 14698-1, Cleanrooms and associated controlled environments — Biocontamination control — General principles and methods
• China GMP (2010 Revision) and EU GMP Annex 1 (Manufacture of Sterile Medicinal Products), which define grade-specific settling microbe limits
• GB 50591-2010, Code for construction and acceptance of cleanrooms
• GB 15982 for hygiene evaluation in hospital environments

Settling microbe testing is typically performed alongside airborne (viable) microbe testing using active air samplers, surface contact plate testing, and glove or garment sampling, forming a complete environmental monitoring (EM) program for aseptic and controlled manufacturing.

Testing Samples

Settling microbe concentration testing applies to any controlled environment where microbiological contamination must be quantified and controlled. Typical test environments include:

Pharmaceutical and Biopharmaceutical Cleanrooms

Sterile and non-sterile drug manufacturing areas classified as Grade A, B, C, and D (or ISO Class 5–8 equivalents), including aseptic filling lines, lyophilizer loading zones, formulation and preparation rooms, and sterile packaging areas. Both at-rest (static) and operational (dynamic) states may be evaluated.

Medical Device Manufacturing Facilities

Production environments for sterile single-use devices, implants, catheters, syringes, and sterilization packaging areas, where airborne bioburden directly affects product sterility assurance.

Healthcare and Hospital Controlled Environments

Hospital operating theatres, intensive care units, central sterile supply departments, pharmaceutical intravenous admixture centers, and isolation wards, where air hygiene is closely linked to healthcare-associated infection control.

Food, Cosmetics, and Laboratory Environments

Clean processing zones for food, beverages, nutritional products, and cosmetics, as well as biological safety laboratories, animal facilities, and research cleanrooms requiring routine biocontamination verification.

Testing Items

The principal test item is the total settling microbe count, which may be subdivided by culture medium and incubation conditions as follows:

• Total viable aerobic bacterial count, using tryptic soy agar (TSA, also known as soybean-casein digest agar), incubated at 30–35 °C for 48–72 hours
• Yeast and mold (fungal) count, using Sabouraud dextrose agar (SDA), incubated at 20–25 °C for 5–7 days
• Sterility and growth promotion verification of culture media in accordance with pharmacopoeial microbiological media tests
• Evaluation of results against grade-specific limits, reported as CFU per plate for the stated exposure time (commonly CFU/4 h)

For most pharmaceutical cleanroom applications, the total aerobic count on TSA is the primary reporting item, while fungal testing is added where product or process risk assessments identify mold contamination as a relevant hazard.

Testing Methods

Principle of the Settle Plate Method

Viable particles suspended in the air settle gravitationally onto the exposed agar surface. After incubation, each viable microorganism or aggregate multiplies into a visible colony. The colony count directly reflects the microbial deposition rate at that location and time, providing a practical estimate of contamination risk to exposed product and surfaces.

Sampling Point Selection and Layout

The minimum number of sampling points is determined according to the cleanroom area, following the sampling point tables in GB/T 16294-2010, which are consistent with the airborne particle counting requirements of the GB/T 16292 series. Points are positioned at working height, typically 0.8 to 1.5 meters above the floor, within the breathing and operating zone of personnel. Additional points are placed at critical risk locations, such as immediately adjacent to open product or filling nozzles. Plates should be kept away from air returns, walls, heat sources, and direct high-velocity supply air streams that would distort natural sedimentation.

Exposure Procedure

The test environment is thoroughly cleaned and disinfected, and the HVAC system is allowed to run for a sufficient stabilization period before testing. In operational testing, normal production activity, personnel, and equipment are present to capture worst-case conditions. Sterile plates are placed at the designated points, lids are carefully opened without disturbing the medium, and exposure proceeds for the specified duration, commonly 30 minutes for qualification testing and up to a maximum of 4 hours for routine monitoring. Personnel must wear appropriate cleanroom garments, minimize movement, and never reach over or talk above open plates. Temperature, humidity, differential pressure, occupancy state, and exposure duration are recorded.

Incubation and Colony Counting

After exposure, lids are closed and plates are inverted and transferred promptly to incubators. Bacterial plates on TSA are incubated at 30–35 °C for 48–72 hours; fungal plates on SDA are incubated at 20–25 °C for 5–7 days. Colonies are counted with a colony counter or magnifying aid, and total CFU per plate is recorded. Negative control plates from the same media batch are incubated in parallel to confirm background sterility.

Result Expression and Acceptance Criteria

Results are reported as the average colony count per plate for the stated exposure time. Under China GMP and EU GMP Annex 1, settle plate limits are expressed per 4-hour exposure as follows:

• Grade A (ISO Class 5 equivalent): fewer than 1 CFU
• Grade B: not more than 5 CFU
• Grade C: not more than 50 CFU
• Grade D: not more than 100 CFU

Excursions above limits require documented investigation, including review of cleaning and disinfection records, personnel behavior, HVAC performance, and media controls, followed by corrective and preventive actions.

Quality Assurance of the Test

Culture media must pass sterility and growth promotion testing against reference strains in accordance with applicable pharmacopoeial chapters before use. Incubators and timers must be calibrated, and testing personnel must be trained in aseptic technique. Many manufacturers engage accredited third-party laboratories to perform settling microbe testing during cleanroom certification, ensuring independent and traceable results.

Applications

Settling microbe concentration testing supports a wide range of quality, regulatory, and engineering activities, including:

• Cleanroom qualification and requalification in as-built, at-rest, and operational states
• Routine environmental monitoring programs for sterile pharmaceutical and medical device manufacturing
• Support of aseptic process simulations (media fills) and sterility assurance documentation
• Hospital hygiene assessment of operating theatres and critical care areas
• Verification of cleaning, disinfection, and HVAC system performance after maintenance or modification
• Data packages for GMP inspections, customer audits, and regulatory submissions
• Investigation of contamination events and evaluation of corrective actions

Because the method directly reflects the deposition of viable particles onto surfaces, it is particularly valuable wherever open product, components, or sterile surfaces are exposed to room air.

FAQ

What is the difference between settling microbe and airborne microbe testing?

Settling microbe testing is a passive method that measures microorganisms depositing onto an exposed plate over time, reported as CFU per plate per exposure period. Airborne microbe testing uses an active air sampler that draws a known volume of air through or onto collection media, reporting results as CFU per cubic meter. The two methods are complementary: settle plates reflect surface deposition risk, while active sampling quantifies actual air concentration.

How long should settle plates be exposed?

For cleanroom qualification per GB/T 16294, an exposure of about 30 minutes is typical. For routine GMP monitoring, plates may be exposed for up to 4 hours, which is the maximum generally accepted duration because media desiccation increasingly inhibits microbial recovery during prolonged exposure.

Should testing be performed at-rest or in operational state?

At-rest testing verifies the installed performance of the cleanroom after cleaning and system stabilization, while operational testing captures the worst case with personnel, equipment, and production activity present. Most qualification protocols include both conditions, and routine monitoring is performed in the operational state.

What factors can cause falsely high or low results?

Improper plate handling, talking or reaching over open plates, drafts from supply diffusers, contaminated media, inadequate disinfection before testing, and incorrect incubation conditions can all distort results. Strict adherence to layout, gowning, and media quality requirements is essential for reliable data.

How often should settling microbe monitoring be performed?

Frequency is risk-based and defined in the site environmental monitoring program. Grade A and Grade B aseptic areas are monitored during every production shift, while lower-grade areas are typically monitored weekly or monthly. Full requalification testing is generally performed at least annually and after major facility changes.

Can settle plate testing replace active air sampling?

No. Settle plates quantify microbial deposition and are best suited to assessing contamination risk at exposed surfaces, whereas active air samplers quantify volumetric air bioburden. Regulatory expectations, including those of China GMP and EU GMP Annex 1, require both methods as part of a comprehensive contamination control strategy.